(PharmaNewsWire.Com, April 18, 2017 ) Publisher Drug Report, "Boostrix- Drug Insights, 2016" highlights the Boostrix marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher's report covers the Global Market Assessment of the Boostrix covering the...
(PharmaNewsWire.Com, April 18, 2017 ) Publisher Drug Report, "Dysport- Drug Insights, 2016" highlights the Dysport marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher's report covers the Global Market Assessment of the Dysport covering the total...
(PharmaNewsWire.Com, April 18, 2017 ) Publisher's, "Ubiquitin Specific Proteases (USP) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Ubiquitin Specific Proteases (USP) Inhibitors. The Publisher's Report covers...
(PharmaNewsWire.Com, April 18, 2017 ) Publisher's, "Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitors. The Publisher's...
(PharmaNewsWire.Com, April 18, 2017 ) Publisher Drug Report, "Lucentis- Drug Insights, 2017" highlights the Lucentis marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher's report covers the Global Market Assessment of the Lucentis covering the...
(PharmaNewsWire.Com, April 18, 2017 ) Publisher's, "Hyperoxaluria-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Hyperoxaluria. The Publisher's Report covers the product profiles in various stages of development including...
(PharmaNewsWire.Com, April 18, 2017 ) Publisher's, "Acute Sensorineural Hearing Loss-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Acute Sensorineural Hearing Loss. The Publisher's Report covers the product profiles...
(PharmaNewsWire.Com, April 18, 2017 ) Publisher's, "Contact Dermatitis-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Contact Dermatitis. The Publisher's Report covers the product profiles in various stages of development...
(PharmaNewsWire.Com, April 18, 2017 ) Publisher's, "Congenital Heart Disease-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Congenital Heart Disease. The Publisher's Report covers the product profiles in various stages...
(PharmaNewsWire.Com, April 18, 2017 ) Publisher's, "Adenocarcinoma Of The Gastroesophageal Junction-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Adenocarcinoma Of The Gastroesophageal Junction. The Publisher's Report...
(PharmaNewsWire.Com, April 18, 2017 ) Publisher's, "Adenosine A3 Receptor Antagonists-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Adenosine A3 Receptor Antagonists. The Publisher's Report covers the product profiles...
(PharmaNewsWire.Com, April 18, 2017 ) Publisher's, "Anti-CD274 (PD-L1) Antibody-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD274 (PD-L1) Antibody. The Publisher's Report covers the product profiles in various...
(PharmaNewsWire.Com, April 18, 2017 ) Juvenile Macular Degeneration (Stargardt Disease)-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Juvenile Macular Degeneration (Stargardt Disease). The Report covers the product...
(PharmaNewsWire.Com, April 18, 2017 ) According to Publisher, the Global Electronic Medical Records market is accounted for $24.02 billion in 2015 and is expected to reach $36.5 billion by 2022 growing at a CAGR of 6.05% from 2015 to 2022. Growing incidence for number of diseases and rapidly increasing...
(PharmaNewsWire.Com, April 18, 2017 ) According to Publisher, the Global Human Microbiome Market is accounted for $130.23 million in 2015 and is expected to reach $521.23 million by 2022 growing at a CAGR of 21.9% during the forecast period. Increasing incidence of lifestyle diseases, growing geriatric...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: